Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FIVE9, INC. (FIVN)

  • Business News
  • March 27, 2026, 22:20 UTC
  • 3
  • 1 comments

Five9 Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Five9, Inc. - FIVN

Market reaction Comment Full text

ResMed Inc (RMD)

  • Business News
  • March 27, 2026, 22:18 UTC
  • 3
  • 1 comments

ResMed Inc. Daily Stock Update

Market reaction Comment Full text

VANECK BITCOIN ETF (HODL)

  • Business News
  • March 27, 2026, 22:13 UTC
  • 2
  • 1 comments

21shares Announces Distributions on TETH and TSOL

Market reaction Comment Full text

IMMUNITYBIO, INC. (IBRX)

  • Business News
  • March 27, 2026, 22:00 UTC
  • 3
  • 1 comments

IBRX ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of ImmunityBio, Inc. Investors

Market reaction Comment Full text

FRONTLINE PLC (FRO)

  • Business News
  • March 27, 2026, 21:45 UTC
  • 2
  • 1 comments

FRO – Changes to the Board composition

Market reaction Comment Full text

ENVERIC BIOSCIENCES, INC. (ENVB)

  • Business News
  • March 27, 2026, 21:40 UTC
  • 2
  • 1 comments

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025

Market reaction Comment Full text

MAGNA INTERNATIONAL INC (MGA)

  • Business News
  • March 27, 2026, 21:35 UTC
  • 2
  • 1 comments

Magna Posts 2025 Annual Report

Market reaction Comment Full text

InMed Pharmaceuticals Inc (INM)

  • Business News
  • March 27, 2026, 21:34 UTC
  • 3
  • 1 comments

Email Campaign - Mar 27, 2026, 1:49 PM

Market reaction Comment Full text

ELECTRA BATTERY MATERIALS CORP (ELBM)

  • Business News
  • March 27, 2026, 21:28 UTC
  • 1
  • 1 comments

Electra Restarts Construction and Reports 2025 Financial Results

Market reaction Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Business News
  • March 27, 2026, 21:24 UTC
  • 6
  • 1 comments

New New SEC Form - Altamira Therapeutics

Market reaction Comment Full text
  • Previous
  • 589
  • 590
  • 591
  • 592
  • 593
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235879)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143296)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin